Longitudinal Study Reveals Non-Linear Trajectory of Cerebrovascular Lesions in Patients with Down Syndrome

A study from Sant Pau Research Institute shows that cerebrovascular lesions in Down syndrome can decrease over time, challenging views on Alzheimer's progression.

By: AXL Media

Published: Mar 19, 2026, 5:52 AM EDT

Source: Information for this report was sourced from Institut de Recerca Sant Pau

Redefining Vascular Damage as a Dynamic Process

A groundbreaking longitudinal study has challenged the scientific consensus that cerebrovascular lesions in individuals with Down syndrome are strictly permanent and irreversible. Researchers at the Institut de Recerca Sant Pau utilized repeated magnetic resonance imaging to track the evolution of white matter hyperintensities, which are typically viewed as markers of small vessel disease. The findings reveal that these lesions do not follow a simple, cumulative path, instead, they exhibit significant fluctuations, with some participants showing a measurable reduction in lesion volume over several years.

The Significance of the Down Syndrome Clinical Model

The study focused on adults with Down syndrome because this population represents a robust model for understanding Alzheimer’s disease, as nearly all individuals develop characteristic proteinopathies by age 40. By following 80 adults with Down syndrome alongside a neurotypical control group, the team was able to move beyond "snapshots" provided by previous cross-sectional research. This longitudinal approach allowed the researchers to witness the "movie" of the disease, confirming that the trajectory of brain alterations is far more heterogeneous than previously understood.

Observations of Lesion Reduction in Symptomatic Stages

The data indicates that while vascular changes remain relatively stable until approximately age 40, the period following the onset of Alzheimer’s symptoms is marked by intense variability. Surprisingly, the most pronounced reductions in white matter hyperintensity volumes occurred in individuals who had already transitioned into the symptomatic stages of dementia. This suggests that the lesions are not merely static scars but may reflect active biological processes that can subside or change in response to the broader progression of neurodegeneration.